SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Patient Opinion Leaders: The New KOLs for Pharma?

[August 20, 2014]

Research and Markets: Patient Opinion Leaders: The New KOLs for Pharma?

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/vl8zgq/patient_opinion) has announced the addition of the "Patient Opinion Leaders: The New KOLs for Pharma?" report to their offering.

This report examines the emergence of patient opinion leaders (POLs), the extent and nature of their influence and how pharma companies can best work with these people. POLs are defined as people who live with a disease and who have attracted large numbers of followers online because of the extent of their knowledge and their ability to encourage others to raise their expectations of their healthcare systems.

POLs are important to pharma mainly because of their role in changing the social contract patients have with their physicians that is so central to conventional healthcare. As patients themselves, they also have a valuable role as sources of feedback for pharma on how products are taken in the real world.

This report examines how they are driving a revolution in healthcare, how they are being recruited by pharma companies to better understand eal-world disease issues and how their influence differs massively depending on the therapeutic area they work in. It looks to the US where the empowerment movement is strongest because the nature of private markets encourages patients to function more like consumers than in the tax-funded healthcare systems of Europe. It also looks to areas such as cancer, which are leading the empowerment movement because of the nature of the condition, the rapidly changing options for treatment and the high prices.


The conclusions are clear: to work effectively with POLs, pharma companies must understand that their main motivation is to raise the expectations of their patient communities about what they can expect from healthcare. And they are borne out via several case studies of how pharma is supporting these goals by employing POLs directly, by how they are focusing their marketing messages and, in several other ways, seeking how they can help patients help themselves to feel more confident about managing their healthcare.

Key Topics Covered:

Chapter 1: Introduction

Chapter 2: Why POLs matter to pharma

  • Influencing doctors on treatment decisions
  • Driving transparency of medical information
  • Forcing innovation in healthcare systems
  • Becoming patient advocates - lobbyists for change
  • Advancing medical literacy among patients

Chapter 3: The evidence for POL influence

  • Social media empowers POLs
  • The Diabetes Influence Study
  • Can patient influence be measured?
  • Influence goes beyond quantitative metrics
  • Patterns of influence

Chapter 4: How pharma can best engage with POLs

  • Segment patients by motivation, not demographics
  • Know what is expected of pharma
  • Help to build patient confidence
  • Support patients to help themselves
  • Focus on outcomes that patients view as important
  • Seek to understand the real patient journey
  • Employ patient leaders directly
  • Understand what drives POLs
  • Learn from the US

Chapter 5: Conclusions

For more information visit http://www.researchandmarkets.com/research/vl8zgq/patient_opinion


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy